| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 09/01/1994 | WO1994019352A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same |
| 09/01/1994 | WO1994019026A1 5-ht1a ligands |
| 09/01/1994 | WO1994019024A2 TECHNETIUM-99m LABELED PEPTIDES FOR DIAGNOSTIC IMAGING |
| 09/01/1994 | WO1994018999A1 A mutant protein and methods and materials for making and using it |
| 09/01/1994 | WO1994018954A1 Methods for in vivo delivery of biologics and compositions useful therefor |
| 09/01/1994 | CA2156158A1 Meso-tetraphenyl porphyrin complex compounds, process for preparing the same and pharmaceuticals containing the same |
| 08/30/1994 | US5342925 Radioactive compositions for soft tissue tumors |
| 08/30/1994 | US5342606 Polyazamacrocyclic compounds for complexation of metal ions |
| 08/30/1994 | US5342604 Bone disorders |
| 08/30/1994 | US5342283 Endocurietherapy |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0425537B1 Method for myocardial infarct risk assessment |
| 08/24/1994 | CN1025735C Process for preparing isothiocyanato functionalized metal complexes |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | WO1994017829A1 Directed biodistribution of small molecules |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | DE4315002C1 Vascular implant |
| 08/18/1994 | CA2154667A1 Directed biodistribution of small molecules |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/17/1994 | EP0610398A1 Contrast media |
| 08/16/1994 | US5338864 Hexadentate ligands useful in radiographic imaging agents |
| 08/16/1994 | US5338852 Anticholinergic compounds |
| 08/16/1994 | US5338744 Angiotensin II antagonists used to treat reproductive functions associated with AT2 receptors |
| 08/16/1994 | US5338686 Method for measuring in vivo synthesis of biopolymers |
| 08/16/1994 | CA1331458C Paramagnetic compounds |
| 08/16/1994 | CA1331450C Diethylenetriamine pentaacetic acid derivatives |
| 08/10/1994 | EP0609336A1 Use of prostacyclin derivatives to prevent or treat disorders of the microcirculating system when x-ray, nmr or ultrasonic contrasting agents are administered |
| 08/10/1994 | EP0587770A4 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 08/09/1994 | US5336762 Polychelating agents for image and spectral enhancement (and spectral shift) |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
| 08/09/1994 | US5336482 Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones |
| 08/04/1994 | WO1994016742A1 Iodine-containing fluorocarbon contrast agents |
| 08/04/1994 | WO1994016741A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | WO1994016735A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/04/1994 | WO1994016734A1 Amplified direction of effector groups to specific target cells in an animal |
| 08/04/1994 | CA2154896A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | CA2154471A1 Amplified direction of effector groups to specific target cells in an animal |
| 08/04/1994 | CA2132632A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/03/1994 | CN1090286A Chelans possessing ortho ligating functionality and complexes thereof |
| 08/02/1994 | US5334728 Dopamine receptor ligands and imaging agents |
| 08/02/1994 | US5334708 Method for radiolabeling monovalent antibody fragments |
| 08/02/1994 | US5334371 Marcocyclic polyaza bicyclo compounds containing 5 or 6 membered rings, and method for MRI |
| 08/02/1994 | US5334369 Platelet receptor antagonists useful in detecting intravascular platelet aggregation |
| 07/27/1994 | EP0607126A1 Complex for in-vivo target localization |
| 07/26/1994 | US5332812 Solid-phase substrate containing modified heparin |
| 07/26/1994 | US5332567 Detection and treatment of infections with immunoconjugates |
| 07/26/1994 | CA1331007C Radioiodinated benzamides and method of their use as radioimaging agents |
| 07/21/1994 | WO1994015647A1 Hexadentate ligands useful in radiographic imaging agents |
| 07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
| 07/21/1994 | WO1994009625A3 Stabilization of fluorocarbon emulsions |
| 07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
| 07/20/1994 | EP0607103A2 Somatostatin analogs containing chelating groups and their radiolabeled compositions |
| 07/20/1994 | EP0606683A2 Means for diagnosis of angiogenic diseases |
| 07/20/1994 | EP0606212A1 Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system |
| 07/20/1994 | EP0449824B1 Method of localizing and quantifying regional energy metabolism in a warm-blooded living being and composition therefor |
| 07/20/1994 | CN1089508A Micropartical agent made of biologicaldegradatable copolymer |
| 07/19/1994 | US5330738 Technetium-99m complexes for use as radiopharmaceuticals |
| 07/19/1994 | US5330737 Radionuclide complexes, radiography |
| 07/14/1994 | CA2113245A1 Agents for the diagnosis of vascular diseases |
| 07/13/1994 | EP0605489A1 Modified peptide derivatives |
| 07/13/1994 | CA2113121A1 Peptides |
| 07/12/1994 | US5328992 Metal complexes of polyethylene glycol carbamate derivatives of desferrioxamine B |
| 07/12/1994 | US5328679 Diagnostic imaging, tumor detection |
| 07/12/1994 | US5328678 Having a large neutron capture cross-section and forming isotope emittting alpha particles when bombarded with neutrons |
| 07/07/1994 | WO1994014477A1 Polyhydric phenol compounds |
| 07/07/1994 | WO1994011509A3 Peptides and anti-sense peptides with broad neoplastic specificity |
| 07/07/1994 | WO1994011508A3 Polypeptides with specificity for neoplasias, kit, and diagnostic, vaccination, and therapeutic methods |
| 07/06/1994 | EP0604830A2 Formation of new specific binding sites on endothelial cells for PAF, its analogues and PAF-antagonists |
| 07/05/1994 | US5326856 Bifunctional isothiocyanate derived thiocarbonyls as ligands for metal binding |
| 07/05/1994 | US5326778 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy |
| 07/05/1994 | US5326551 Nuclear imaging uses of radio-labelled atrial natriuretic factor |
| 06/29/1994 | EP0354923B1 Method for labelling antibodies with a metal ion |
| 06/28/1994 | US5324824 Kits containing lyophilized adducts and measured amounts of reducing agents, for labeling cells or tissues |
| 06/28/1994 | US5324502 Radiopharmaceuticals for imaging the heart |
| 06/28/1994 | CA1330422C Reduction of neurotoxic effects of cytotoxic agents |
| 06/23/1994 | WO1994013327A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/23/1994 | WO1994007542A3 Labelled monocyte chemoattractant protein material and medical uses thereof |
| 06/23/1994 | CA2151614A1 Immunoreactive reagents employing dihydrofolate reductase |
| 06/21/1994 | US5322929 Radiolabeled technetium chelates for use in renal function determinations |
| 06/21/1994 | US5322681 Chelating compounds |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/16/1994 | DE4339053A1 New clathrates of nitrogen-contg. fullerene analogues - contg. active agents releasable by irradiation |
| 06/15/1994 | EP0602004A1 Peptides having T cell helper activity |
| 06/15/1994 | EP0602003A1 Peptides having T cell helper activity |
| 06/15/1994 | EP0600992A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 06/15/1994 | EP0600875A1 Purification of recombinant apolipoprotein e from bacteria |
| 06/15/1994 | EP0600869A1 Synthetic peptides for arterial imaging |
| 06/14/1994 | US5320956 Ovarian, esophageal and cervical carcinomas |
| 06/14/1994 | US5320825 Serotonin reuptake inhibitors for S.P.E.C.T. imaging |
| 06/14/1994 | US5320824 Bound to insoluble particles of sufficient size to prevent leakage, nondamaging to underlying cartilage |
| 06/09/1994 | WO1994012466A1 Fatty acid derivatives and pharmaceutical compositions containing them |
| 06/09/1994 | WO1994012216A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/09/1994 | WO1994008949A3 Metal-oxime chelates for use as radiopharmaceutical agents |
| 06/09/1994 | CA2150477A1 Sequential targeting of tumor sites with oligonucleotide conjugates of antibody and complementary oligonucleotide conjugates of chelated radionuclide |
| 06/08/1994 | EP0600528A1 Method of grinding pharmaceutical substances |
| 06/08/1994 | EP0599979A1 LABELLED $g(b)-AMYLOID PEPTIDE AND ALZHEIMER'S DISEASE DETECTION |
| 06/08/1994 | EP0445236B1 Tumor imaging with technetium labeled carbohydrates |
| 06/08/1994 | CN1087546A Manufacture method for medicine box of kidney-function developer |
| 06/01/1994 | EP0599303A2 Peptide conjugate |
| 06/01/1994 | EP0598837A1 Amino acid, ester and/or catechol contrast agents for mri |